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A bacterium originally described as Hafnia alvei induces diarrhea in rabbits and causes epithelial damage
similar to the attachment and effacement associated with enteropathogenic Escherichia coli. Subsequent studies
identified similar H. alvei-like strains that are positive for an intimin gene (eae) probe and, based on DNA
relatedness, are classified as a distinct Escherichia species, Escherichia albertii. We determined sequences for
multiple housekeeping genes in five E. albertii strains and compared these sequences to those of strains
representing the major groups of pathogenic E. coli and Shigella. A comparison of 2,484 codon positions in 14
genes revealed that E. albertii strains differ, on average, at ⬃7.4% of the nucleotide sites from pathogenic E. coli
strains and at 15.7% from Salmonella enterica serotype Typhimurium. Interestingly, E. albertii strains were
found to be closely related to strains of Shigella boydii serotype 13 (Shigella B13), a distant relative of E. coli
representing a divergent lineage in the genus Escherichia. Analysis of homologues of intimin (eae) revealed that
the central conserved domains are similar in E. albertii and Shigella B13 and distinct from those of eae variants
found in pathogenic E. coli. Sequence analysis of the cytolethal distending toxin gene cluster (cdt) also disclosed
three allelic groups corresponding to E. albertii, Shigella B13, and a nontypeable isolate serologically related to
S. boydii serotype 7. Based on the synonymous substitution rate, the E. albertii-Shigella B13 lineage is estimated
to have split from an E. coli-like ancestor ⬃28 million years ago and formed a distinct evolutionary branch of
enteric pathogens that has radiated into groups with distinct virulence properties.
related to Escherichia and Shigella (18). Additionally, the structure of the O chain of the lipopolysaccharide of E. albertii has
been described and does not resemble that of any known
lipopolysaccharide O chain from E. coli or H. alvei; however,
based on the types of sugar residues and acidity, it could fit into
either group (13).
Based on genotypic analysis, another bacterium, Shigella
boydii serotype 13 (Shigella B13), has also been shown to be a
distant relative of E. coli representing a divergent lineage in
the genus Escherichia (5, 26, 40). E. coli and Shigella have been
described as one genetic species based on DNA-DNA hybridization patterns, and it has been demonstrated that although
the O antigens of Shigella B13 exhibit a reciprocal cross-reaction with E. coli O28 antigens, they are genetically distinct (5).
Additionally, Shigella B13 is the only member of the E. coliShigella group that can be reliably separated by bulk DNADNA hybridization techniques (5).
Nucleotide sequencing of multiple conserved genes has supported the hypothesis that E. coli and Shigella are the same
genetic species and has also provided evidence that Shigella
B13 belongs to a divergent branch outside the diversity of
E. coli and Shigella. Furthermore, three main groups of Shigella
strains are apparent, each including serotypes from the traditional Shigella species: S. boydii, S. flexneri, S. sonnei, and
S. dysenteriae (26, 40). An independent multilocus sequence
typing (MLST) analysis of a variety of serotypes of Shigella and
enteroinvasive E. coli (EIEC) strains confirmed the presence
of these three groups and supported the placement of Shigella

In the early 1990s, Hafnia alvei was first implicated as a
causative agent of diarrhea (2). At the International Center for
Diarrheal Disease Research, Dhaka, Bangladesh, clinical isolates of H. alvei were found to differ from representative
H. alvei strains by phenotypic and genotypic assays, including
the presence of an intimin gene (eae) homologous to the gene
critical for the attaching-effacing phenotype of enteropathogenic Escherichia coli (EPEC) (3). A subsequent study identified similar H. alvei-like strains that were positive for the eae
probe and, based on partial 16S rRNA sequences, were found
to be more closely related to EPEC than to eae-negative
H. alvei (20).
Further investigation led to the recognition of these H. alveilike strains as a new Escherichia species, Escherichia albertii,
based on the results of DNA-DNA hybridization and 16S
rRNA gene sequence data (18). DNA relatedness, assessed by
DNA-DNA hybridization, was highest (ranging from 54 to
64%) among E. albertii, E. coli, and Shigella flexneri, lowest (9
to 17%) between E. albertii and H. alvei, and intermediate (16
to 45%) among E. albertii and the four Escherichia species
E. blattae, E. fergusonii, E. hermanii, and E. vulneris (18). Analysis of 16S rRNA gene sequences reinforced the conclusion
that E. albertii does not belong to H. alvei but is most closely
* Corresponding author. Mailing address: Microbial Evolution Laboratory, 165 Food Safety & Toxicology Building, Michigan State University, East Lansing, MI 48824. Phone: (517) 432-3100, ext. 178. Fax:
(517) 432-2310. E-mail: whittam@msu.edu.
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TABLE 1. Sources of E. albertii and Shigella strains

Strain

Species or type

Host

Locale

Sourcea

9194
10790
10457
12502
19982
2045-54
2046-54
1610-55
5216-70
603-73
3552-77
3553-77
3554-77
3555-77
3556-77
3557-77
3052-94
3053-94
3103-99
C-425 (ATCC 12032)
616
K-694
K-1
3097-02

E. albertii
E. albertii
E. albertii
E. albertii
E. albertii
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B7
Nontypeable

Human (child)
Human (child)
Human (child)
Human (child)
Human (child)
Human (child)
Human (child)
Monkey
Human
Human
Human
Human
Human
Human
Human
Human
Human (infant)
Human (19 yr)
Human (40 yr)
Human
Human
Human
Human
Human

Bangladesh
Bangladesh
Bangladesh
Bangladesh
Bangladesh
Egypt
Egypt
United States (Fla.)
United States (Ohio)
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
New Zealand
New Zealand
United States (Ill.)
No data
No data
Bangladesh
Bangladesh
United States (Wis.)

J. M. Janda
J. M. Janda
J. M. Janda
J. M. Janda
J. M. Janda
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
CDC
ATCC
CDC
K. A. Talukder
K. A. Talukder
CDC

a

CDC, Centers for Disease Control and Prevention; ATCC, American Type Culture Collection.

serotypes into distinct groups within the diversity of the E. coli
population; this study also placed nontypeable Shigella strains
into these three groups (6).
Attachment and effacement appear to be critical components of the virulence of E. albertii (2, 3, 19). In Citrobacter
rodentium and diarrheagenic E. coli, attaching-effacing lesion
formation is mediated by intimin, an outer membrane protein
encoded by the eae gene, and other components of the locus of
enterocyte effacement pathogenicity island (34). Intimin is a
highly polymorphic protein with more than 20 distinct subtypes
and has been discovered in clinical isolates and animal sources
(1, 25, 41, 54). The C-terminal region of the protein is the
surface-exposed, immunogenic domain, which functions in
binding to epithelial cells via the translocated bacterial receptor, Tir (30). In contrast, the central region is a highly conserved transmembrane domain with homology to the invasins
of pathogenic Yersinia (53). Sequence comparisons have shown
that intimin subtypes are encoded by distinct eae alleles with
mosaic structures that presumably have arisen through lateral
gene transfer and recombination (33, 48).
A second putative virulence factor discovered in E. albertii is
cytolethal distending toxin (CDT) (38). In addition to strains of
pathogenic E. coli and Shigella (22, 24), CDT is dispersed
phylogenetically and has been found in Campylobacter spp.
(23), Haemophilus ducreyi (8), Actinobacillus actinomycetemcomitans (46), and Helicobacter spp. (7, 50, 52). Cultured mammalian cell lines exposed to CDT become arrested in the G1 or
G2 phase of the cell cycle, in association with cell distension
and eventually death (9, 27, 28, 36). In all bacterial species in
which CDT activity has been demonstrated, three closely
linked genes (cdtA, cdtB, and cdtC) have been associated with
cytotoxic activity (28, 36, 37, 44). Although genetic studies have
indicated that all three genes are necessary to transfer full
activity to a noncytotoxic E. coli strain (9, 28, 36, 37), cdtB has

been implicated as encoding the enzymatically active subunit
(27, 28). The CdtB subunit is homologous to a class of phosphodiesterases that includes nucleases, and it has been demonstrated that CdtB damages host cell DNA through DNase
I-like activity in vitro (12, 17, 27, 32). This activity triggers the
DNA damage checkpoint response (9), which results in cell
cycle arrest (9, 12, 27, 28). The CdtA and CdtC subunits function together to mediate the binding of the AB2 holotoxin to
eukaryotic cells and the subsequent delivery of CdtB to the
cytoplasm (10, 29, 35).
The purpose of the study reported here was to elucidate the
phylogenetic relationships of E. albertii and its relatives that
express Shigella B13- and S. boydii serotype 7 (Shigella B7)related antigens. In addition, we characterize the genes encoding the putative virulence factors intimin and CDT, whose role,
if any, in the pathogenesis of E. albertii and relatives is not
known. We propose a model, based on MLST analysis and
supported by virulence gene sequences, in which the divergence of the E. albertii lineage preceded the radiation of pathogenic E. coli and Shigella. We also demonstrate that the E. albertii lineage includes other unusual strains, such as divergent
Shigella B13 (5) and two nontypeable clinical isolates.

MATERIALS AND METHODS
Bacterial strains. All strains were grown overnight in Luria-Bertani broth at
37°C. The strains examined included 5 E. albertii human clinical isolates (18, 20),
17 Shigella B13 isolates, 1 nontypeable strain, and 1 Shigella B7 isolate (Table 1).
We use the nomenclature of Pupo et al. (40) in referring to the Shigella serotypes
as B13 and B7.
DNA isolation. Genomic DNA was isolated from 2 ml of overnight culture by
using a Puregene DNA isolation kit (Gentra Systems Inc., Minneapolis, Minn.).
DNA preparations were quantified by using a NanoDrop ND-1000 UV-Vis
spectrophotometer (NanoDrop Technologies, Wilmington, Del.). DNA preparations were diluted to a final concentration of 100 ng/l and stored at 4°C.
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MLST analysis. The nucleotide sequences of internal fragments of the following genes were obtained for MLST analysis: arcA, aroE, aspC, clpX, cyaA,
dnaG, fadD, grpE, icdA, lysP, mdh, mtlD, mutS, rpoS, and uidA. The analysis
included 34 E. coli and Shigella strains and 2 Salmonella strains for comparison.
Information on primers and protocols for MLST can be found at website http:
//www.shigatox.net/mlst. Sequence analysis was performed with MEGA2 software (version 2.0; Pennsylvania State University, University Park).
16S rRNA gene sequencing. The forward primer S-D-Bact-0008-a-S-20 and the
reverse primer S-*-Univ-1492-b-A-21 (45) were used to amplify bacterial 16S
rRNA genes by PCR under the following conditions: 94°C for 10 min; 35 cycles
of 92°C for 1 min, 58°C for 1 min, and 72°C for 1 min; and 72°C for 5 min.
Additional internal sequencing primers included 16SintF1 (5⬘-CGG AGG GTG
CAA GCG TTA AT-3⬘), 16SintF2 (5⬘-ACC CTT ATC CTT TGT TGC-3⬘),
16SintR1 (5⬘-CCA GGT AAG GTT CTT CGC GT-3⬘), and 16SintR2 (5⬘-AGT
ACT TTA CAA CCC GAA GG-3⬘).
Diagnostic multiplex PCR. The following primers were designed and used for
diagnostic multiplex PCR: clpX_28F (5⬘-TGG GCT CGA GTT GGG CA-3⬘),
clpX_411R (5⬘-TCC TGC TGC GGA TGT TTA CG-3⬘), lysP_107F (5⬘-GGG
CGC TGC TTT CAT ATA TTC TT-3⬘), lysP_358R (5⬘-TCC AGA TCC AAC
CGG GAG TAT CAG GA-3⬘), mdh_50F (5⬘-CTG GAAGGC GCA GAT GTG
GTA CTG ATT-3⬘), and mdh_164R (5⬘-CTT GCT GAA CCA GAT TCT TCA
CAA TAC CG-3⬘).
eae sequencing. The entire eae gene, which encodes intimin, was sequenced for
representative strains 19982, K-694, C-425, 3555-77, 3097-02, and K-1. PCR and
sequencing primers included cesT-F9 (5⬘-TCA GGG AAT AAC ATT AGA
AA-3⬘), eae-F1 (5⬘-ACT CCG ATT CCT CTG GTG AC-3⬘), eae-R3 (5⬘-TCT
TGT GCG CTT TGG CTT-3⬘), and escD-R1 (5⬘-GTA TCA ACA TCT CCC
GCC CA-3⬘). Internal sequencing primers included eae-F01s (5⬘-AAG CAA
CAT GAC CGA TGA CA-3⬘), eae-F02s (5⬘-GGC GAA TAC TGG CGA GAC
TA-3⬘), eae-F05s (5⬘-AGT TAA ATG CAA ATG GCG GT-3⬘), eae-F06s (5⬘GTA ACG GAC TTT ACG GCT GAT A-3⬘), eae-F07s (5⬘-GCC TAA TAG
CAT AGT GAG CGT T-3⬘), eae-F08s (5⬘-GTG ATA ATC AAA CCG CAA
CT-3⬘), eae-F09s (5⬘-CGA CCT TAG GGA CGT TAA GT-3⬘), eae-F10s (5⬘GCT TGT TAG TGC CCG AGT TC-3⬘), eae-R02s (5⬘-GGG CGC TCA TCA
TAG TCT TT-3⬘), eae-R05s (5⬘-GGT AAT AAT GCC TGT ATT AG-3⬘),
eae-R06s (5⬘-AGT GAG CGA GAC TGA AGT TG-3⬘), eae-R08s (5⬘-GTC
GCG GTA TAA GTA AT-3⬘), eae-R09s (5⬘-TTC CTG GGA ATA ATG TTG
AT-3⬘), eae-R10s (5⬘-TGG CAT GAG CTT ACA GCA TC-3⬘), eae-R11s (5⬘CGG ATA ACG GCT TAC CAT CT-3⬘), and eae-R12s (5⬘-GCA TTA AGC
GCT GAA GTC AT-3⬘).
cdt sequencing. Nucleotide sequences were obtained for an internal fragment
of putative virulence locus cdtB by using the primers VAT2 and WMI1 (39).
Sequences for the cdtABC operon were determined for the four representative
E. coli strains 19982, K-694, 3097-02, and K-1. The following additional primers
were used for PCR and sequencing: cdt_5_flank_F (5⬘-AGG AGA TTT GCC
AAT GTG AT-3⬘), cdt_1101_B_R (5⬘-GTA TCT ACA GCC GTT GAT GG-3⬘),
cdt_1248_B_R (5⬘-GGC AGG CCG ATG AGG TG-3⬘), cdt_2057_R (5⬘-CGT
TTG TTG AAG GTA TGA GAG-3⬘), and cdt_1815_F (5⬘-TCT ATT CAC
ATT CCG CA-3⬘). The following primers were used for internal sequencing:
cdt_584_R (5⬘-CCC GGG AAG CTT GTC ATA-3⬘) and cdt_564_F (5⬘-CTT
TCT ACT GCA CCT TGC CA-3⬘). Primer randR1 (5⬘-TGC CGG GCA A-3⬘)
was used for PCR.
CDT activity assays. CDT activity assays were performed by the method of
Young et al. (51, 52). Bacterial strains were grown overnight with shaking at 37°C
in Luria-Bertani broth. Total bacterial proteins were solubilized with a nonionic
detergent (bacterial protein extraction reagent; Pierce Chemical Co., Rockford,
Ill.) according to the recommendations of the manufacturer. Bacteria were
pelleted by centrifugation at 2,040 ⫻ g for 10 min, suspended in 300 l of
bacterial protein extraction reagent, and vortexed. Insoluble material was removed by centrifugation at 13,800 ⫻ g for 5 min, and soluble proteins contained
in the supernatant were collected and stored at ⫺80°C. HeLa cells were used to
seed 13-mm-diameter circular glass coverslips in 24-well tissue culture plates at
a density of ⬃2 ⫻ 103 per well. Ten microliters of bacterial protein extract was
added to each well, and the plates were incubated in 5% CO2 at 37°C. At
appropriate time points, coverslips were washed with phosphate-buffered saline
and then fixed and stained with a Hema 3 stain set (Fisher Scientific, Hampton,
N.H.). CDT-positive E. coli 493/89 (22) and CDT-negative E. coli K-12 were used
as positive and negative controls, respectively.
To confirm the CDT-positive results, CDT activity assays were also performed
with Shiga toxin-insensitive CHO cells by the method of Scott and Kaper (44).
CHO cells were maintained at 37°C in Ham’s F-12 medium plus glutamine and
supplemented with 10% fetal bovine serum, penicillin, and streptomycin. Cells
were trypsinized and suspended at 2 ⫻ 104 per ml in Ham’s F-12 medium with
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1% fetal bovine serum, penicillin, and streptomycin. The cell suspension was
added to 96-well plates at 150 l per well. Bacterial cultures were grown with
shaking overnight in Trypticase soy broth with 0.6% yeast extract. Aliquots (15 l
per well) of each test supernatant were added in triplicate to freshly plated CHO
cells. Assay mixtures were incubated for 5 days at 37°C in 5% CO2 and then fixed
and stained with the Hema 3 stain set.
Virulence gene profiling. Multilocus virulence gene profiling was performed by
using a Beckman (Fullerton, Calif.) CEQ8000 genetic analysis system as described previously (47) with the following modification: additional labeled primer
sets were used for more extensive profiling of strains to give a total of 30 genes
for fragment analysis, including an mdh control. Several primer sets were obtained from IDT (Coralville, Iowa), Proligo (Boulder, Colo.), and Research
Genetics (Huntsville, Ala.). Cycling conditions were modified to include an
annealing temperature of 50°C and 40 amplification cycles. Additional primer
pairs can be found at website http://www.shigatox.net/mlst.
Nucleotide sequence accession numbers. The nucleotide sequences determined in this study have been submitted to GenBank under accession numbers AY696659 to AY697031. These include accession numbers AY696752 to
AY696755 for sequences for the cdtABC operon from E. coli strains 19982,
K-694, 3097-02, and K-1, respectively.

RESULTS
MLST analysis. In most cases, PCR primers used for amplifying and sequencing of E. coli and Shigella worked successfully for E. albertii, divergent Shigella B13, and related strains.
The exceptions included the uidA gene, which encodes ␤-glucuronidase (a hallmark of typical E. coli) and was amplified in
only five Shigella B13 strains: 5216-70, 3053-94, 3052-94, 355677, and 3557-77. In three strains, E. albertii 12502, Shigella B13
603-73, and Shigella B13 5216-70, a large (⬃1.3-kb) insertion
sequence was present in the region of rpoS used for MLST
analysis. The insertion sequence was removed for analysis. In
Shigella B13 strain 616, rpoS could not be amplified with E. coli
PCR primers.
The results of PCR and sequencing of housekeeping genes
allowed for a comparison of 2,484 homologous codon positions
in 14 genes (uidA not included). E. albertii strains were highly
divergent from E. coli strains, differing on average at ⬃7.4% of
the nucleotide sites from pathogenic E. coli strains (7.3% for
EPEC strain E2348/69 and 7.5% for E. coli O157:H7) and
15.7% from Salmonella enterica serotype Typhimurium LT2.
The E. albertii strains were most closely related to a Shigella
B13 strain (ATCC 12032) (6), differing at only 0.72% of the
nucleotide sites.
To assess the generality of these findings, an additional 16
Shigella B13 strains, 1 nontypeable strain, and 1 Shigella B7related strain were examined. Five of the Shigella B13 strains
(5216-70, 3053-94, 3052-94, 3556-77, and 3557-77) were phylogenetically more closely related to members of the E. coliShigella group than to other Shigella B13 strains (Fig. 1). These
Shigella B13 strains were the same strains in which uidA could
be amplified with E. coli uidA PCR primers. Strain 5216-70
(Fig. 1B) was most closely related to a group of EIEC strains
(EIEC group 2) (6), whereas strains 3053-94, 3052-94, 3556-77,
and 3557-77 were phylogenetically most closely related to each
other and formed a distinct cluster (Fig. 1C); this cluster appears to have descended from an ancestor that also gave rise to
all Shigella and EIEC groups. For clarification, these five
strains are hereafter referred to as atypical Shigella B13 strains.
The remaining Shigella B13 strains, the nontypeable strain, and
the Shigella B7-related strain were most closely related to the
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FIG. 1. Phylogenetic relationships of Shigella B13 strains and the E. albertii lineage. A neighbor-joining tree (MEGA2) was constructed by using
the Tamura-Nei model with gamma correction for the distribution of rates based on 14 housekeeping genes. The E. albertii lineage (A) includes
E. albertii, Shigella B13, and Shigella B7. On the basis of the rate of synonymous substitutions for E. coli and S. enterica (4.7 ⫻ 10⫺9 per site per
year), the E. albertii lineage shared a common ancestor with E. coli and Shigella pathogenic groups ⬃28 million years ago (mya). Atypical S. boydii
strains express the Shigella B13 antigen and do not cluster with the E. albertii lineage but are more similar in their MLST profile to E. coli and
Shigella groups. Shigella B13 strain 5216-70 belongs to EIEC group 2 (B), and four atypical Shigella B13 strains belong to their own cluster within
the diversity of E. coli and Shigella (C). The number of strains examined is in parentheses. NT, nontypeable; EHEC, enterohemorrhagic E. coli.

E. albertii strains and are hereafter collectively referred to as
the E. albertii lineage (Fig. 1A).
Within the E. albertii lineage, ⬃1.1% (82 of 7,470) of nucleotide sites and ⬃0.2% (6 of 2,490) of amino acid sites are
variable. Synonymous substitution rates per 100 nucleotide
sites in housekeeping genes between E. albertii and E. coliShigella range from a low of 10.97 for icdA to a high of 37.99 for
cyaA and average 25.34, compared to an average of 5.21 ⫾ 0.26
(mean and standard deviation) within E. coli-Shigella. Because
there is substantial divergence at every locus, there is no evidence for recent recombination or gene exchange events
between the E. albertii lineage and the E. coli population.
Nonsynonymous substitution rates are much lower in each
comparison, indicating conservative selection of housekeeping
loci and allowing us to measure sequence divergence independently of adaptive evolution (Table 2). It is noteworthy that the
average divergence between E. albertii and E. coli represents
about 40% of the evolutionary distance from E. coli to S. enterica.

We used the combined sequences of the 14 housekeeping
genes to define distinct multilocus sequence types. There were
six different sequence types in the E. albertii lineage, and three
different groups of sequence types can be resolved. One of the
groups contains four sequence types comprised of Shigella B13
strains and nontypeable strain 3097-02. Variability within this
group is low: ⬃0.04% (3 of 7,470) of nucleotide sites and
⬃0.08% (2 of 2,490) of amino acid sites. The remaining two
sequence types each represent their own branch; the E. albertii
strains all belong to one, and Shigella B7-related strain K-1
belongs to the other. In pairwise comparisons, the E. albertii
group varies from the Shigella B13 group at ⬃0.6% of nucleotide sites and ⬃0.01% of amino acid sites and from the Shigella B7-related strain at ⬃0.7% of nucleotide sites and ⬃0.08%
of amino acid sites. The Shigella B7-related strain differs from
the Shigella B13 group by ⬃0.7% of nucleotide sites and
⬃0.1% of amino acid sites (Fig. 1A).
16S rRNA gene sequencing. To assess further the genetic
relatedness of the E. albertii and Shigella B13 strains, we se-
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TABLE 2. Pairwise sequence divergence among strains of the
E. albertii-Shigella B13 lineage (Ea), E. coli (Ec),
and S. enterica (Se)a
dS for:

Locus

dN for:

Ea/Ec

Ea/Se

Ec/Se

Ea/Ec

Ea/Se

Ec/Se

arcA
aroE
aspC
clpX
cyaA
dnaG
fadD
grpE
icdA
lysP
mdh
mtlD
mutS
rpoS

14.71
18.94
32.02
12.48
37.99
41.17
48.61
12.43
10.97
31.19
32.00
32.2
19.01
20.84

44.43
112.57
89.38
48.27
85.85
78.98
120.56
53.97
61.53
80.85
73.63
70.88
55.09
28.5

47.09
104.86
93.63
44.19
53.62
82.81
98.68
46.81
57.87
73.44
58.66
59.54
62.07
26.44

0
1.23
0.31
0
0.01
0.33
0.77
1.02
0
1.84
0.27
0.40
0.57
0.01

0
7.98
4.05
0.77
0.72
11.83
3.81
5.07
1.23
3.77
2.61
3.89
1.13
0.01

0
7.65
4.26
0.76
0.73
11.6
3.17
4.71
1.00
4.09
2.34
3.70
0.85
0

Avg

25.34

67.00

60.65

0.43

3.03

2.86

a

Sequence differences are expressed as the synonymous substitution rate (dS)
per 100 synonymous sites and the nonsynonymous substitution rate (dN) per 100
nonsynonymous sites. Calculations were performed with MEGA2 software.

quenced and analyzed part of the 16S rRNA gene of all members of the E. albertii lineage and atypical Shigella B13 strains.
There were 1.8% (27 of 1,464) variable sites within the lineage
and five distinct sequence types divided into groups corresponding to MLST results: two groups of atypical Shigella B13
strains, one group of E. albertii strains, one group of Shigella
B13 strains, and one group including the Shigella B7-related
strain. In pairwise comparisons within the E. albertii lineage,
the Shigella B13 and B7-related strains were the most similar
(99.86%), and the Shigella B7-related and atypical Shigella B13
strains were the least similar (98.32%).
eae sequencing. The close evolutionary relationships between E. albertii and Shigella B13 strains predicted that these
bacteria should share additional chromosomal genes. We
tested this prediction by attempting to detect, amplify, and
sequence eae homologues in Shigella B13 and related Shigella
strains of the E. albertii lineage. All strains tested were amplified, and an analysis of intimin (eae) sequences in six strains
revealed three distinct eae variants, one in E. albertii strains,
one in the Shigella B13 subcluster, and one in the Shigella
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B7-related strain. The central conserved domain of eae in six
strains of the E. albertii lineage were most similar to each other,
with the iota2 allele (GenBank accession number AF530553)
being the most closely related E. coli allele. The C-terminal
region of the intimin gene (Int280 region), in contrast to the
central conserved region, which varied at 1.2% of nucleotide
sites and 0.9% of amino acid sites within this lineage, differed
at 37.6% of nucleotide sites and 42.3% of amino acid sites
(Table 3). The Int280 region in strains of the Shigella B13
subcluster all have the same sequence, which was most similar
to the iota2 allele sequence; E. albertii and Shigella B7-related
strains, although possessing different alleles, are most closely
related to each other, with the alpha and zeta alleles being the
next most similar alleles (Fig. 2).
cdt sequencing and CDT expression. Partial sequence data
were determined for the cdtB subunit of members of the E. albertii lineage, and complete cdtABC sequences were obtained
for representatives of the distinct subclusters of the E. albertii
lineage. For atypical Shigella B13 strains and Shigella B13
strains 3553-77 and 3555-77, cdtB could not be PCR amplified.
Sequence analysis of cdtABC revealed three allelic groups corresponding to the E. albertii, Shigella B13, and Shigella B7-like
clusters within the lineage, consistent with evolutionary analysis of multiple housekeeping genes. The cdt sequences of the
E. albertii lineage are most similar to the CDT V and CDT III
variants (Fig. 3) originally found in E. coli strain 9142-88, in
sorbitol-fermenting, Shiga toxin-producing E. coli O157:H⫺
strain 493/89, and on E. coli plasmid pVIR. Although the
amino acid residues in CdtB that are important for enzymatic
activity have been conserved in the E. albertii lineage, all members of the Shigella B13 subcluster have a putative stop codon
within the cdtB subunit (Fig. 3). Findings from subsequent
experiments (see below) demonstrated that these strains do
not produce stereotypical CDT activity.
All strains were tested for the ability to produce functional
CDT. HeLa cells exposed to protein extracts from whole-cell
lysates of E. albertii and Shigella B7-related strains exhibited
stereotypical CDT cytopathic effects, including distended cytoplasm and nuclear abnormalities. HeLa cells exposed to protein extracts from Shigella B13 strains exhibited minimal cytopathic effects (Fig. 4), consistent with the hypothesis that the
stop codon in the Shigella B13 subcluster has inactivated the
gene. There were no instances in which CDT activity was de-

TABLE 3. Sequence divergence and properties of the domain and subunits of the intimin alleles (eae) and
CDT gene (cdt) of the E. albertii-Shigella B13 lineagea
Mean ⫾ SD

No. of
Locus

Entire eae
eae 5⬘ region
eae central region
eae 3⬘ region
cdtABC
cdtA
cdtB
cdtC
MLST genes
a
b

Alleles

Polymorphic sites

dS

dN

3
3
3
3
3
3
3
2
6b

513
8
12
493
17
7
6
4
82

16.06 ⫾ 1.06
2.30 ⫾ 0.79
1.50 ⫾ 0.51
41.88 ⫾ 3.30
1.10 ⫾ 0.36
1.06 ⫾ 0.60
0.98 ⫾ 0.54
1.27 ⫾ 0.80
1.34 ⫾ 0.19

8.55 ⫾ 0.63
0.00 ⫾ 0.00
0.20 ⫾ 0.11
21.34 ⫾ 1.59
0.29 ⫾ 0.11
0.46 ⫾ 0.21
0.22 ⫾ 0.14
0.08 ⫾ 0.08
0.03 ⫾ 0.02

See Table 2, footnote a, for definitions.
Number of distinct 14-locus sequence types.

dS/dN

% GC

Codon adaptation
index

1.9
0
7.6
2.0
3.8
2.3
4.4
16.1
44.1

42.0
41.8
45.2
39.7
43.3
45.9
44.0
38.1
52.3

0.282
0.286
0.320
0.253
0.173
0.170
0.174
0.172
0.448
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FIG. 2. Intimin variants of the E. albertii-Shigella B13 lineage. (A) A neighbor-joining tree (MEGA2) based on nucleotide sequences of the eae
central conserved region of intimins of E. coli shows that the sequences of the intimin gene homologues of E.albertii-Shigella B13 strains are most
similar to the sequence of the E. coli iota2 allele. (B) Haplotype plots of the nucleotide differences in the 3⬘ part of the eae gene encoding the Int280
region. The sequences of E. albertii and Shigella B7 strains are similar to the sequence of the iota2 allele of E. coli in the central conserved region
but are most similar to the sequences of the alpha and zeta alleles of E. coli in the Int280 region. (C) Percent amino acid similarities among
representative intimin variants. The lower triangular matrix shows pairwise similarity values for the central conserved region, and the upper
triangular matrix shows values for the Int280 region. The shading highlights close similarities to the intimin domains of the E. albertii-Shigella B13
lineage (tan). C.rod, C. rodentium.

tected for a strain that was found to be negative for cdtB by
PCR. Although none of the strains tested was found to be
positive for Shiga toxin (stx) by multilocus virulence gene profiling, the CDT results were verified by the method of Scott and
Kaper (44) with Shiga toxin-insensitive CHO cells (data not
shown).
Virulence gene profiling. To identify other potential virulence factors, 30 known virulence genes of E. coli and Shigella
were tested for their presence in members of the E. albertii
lineage (Table 4). As expected, strains of the E. albertii lineage
were all positive for eae. In addition, members of the lineage
were positive for at least one locus of E. coli O island 43: ureA
(urease), terC (tellurite resistance), or iha (IrgA homologue
adhesion). Most E. albertii strains were also positive for toxB,
a toxin gene present on E. coli O157 plasmids. None of the
chromosomal E. coli virulence loci examined was present in the
strains examined, but pic, a secreted autotransporter toxin
gene, and set1a, an enterotoxin gene present on the Shigella
chromosome, were present in some strains of the E. albertii
lineage. Although neither of these loci was found in atypical

Shigella B13 strains, the following were present: chromosomal
Shigella virulence factor gene sigA, encoding a secreted autotransporter toxin; shuA, a heme receptor gene on the outer
membrane of S. dysenteriae; E. coli plasmid-carried ehx, an
enterohemolysin gene; pet, an E. coli secreted autotransporter
toxin gene; and astA, the EAST1 heat-stable toxin gene present
in duplicate on both the chromosome and a plasmid of pathogenic E. coli. Atypical Shigella B13 strain 5216-70, which is genetically related to a group of EIEC strains, was not positive
for eae.
Diagnostic multiplex PCR. With the sequence data from the
conserved housekeeping genes, we devised a multiplex PCR to
detect conserved sequences that distinguish members of the
E. albertii lineage from E. coli and Shigella strains. Candidate
sequences with fixed differences between lineages were identified in the lysP and mdh loci. Based on nucleotide polymorphisms, primers lysP_107F and lysP_358R and primers mdh_50F
and mdh_164R were designed to selectively amplify 252- and
115-bp regions, respectively, of the housekeeping genes lysP
and mdh in the E. albertii lineage. As a positive control, prim-

EVOLUTIONARY GENETICS OF E. ALBERTII AND S. BOYDII

VOL. 187, 2005

625

FIG. 3. Multiple sequence alignment of CdtBs from representatives of the five described E. coli alleles, CDT I (44), CDT II (37), CDT III (36),
CDT IV (49), and CDT V (4, 22), and representatives of three distinct alleles of the E. albertii lineage (B13, E.alb., and B7). At amino acid position
41, shown here in a box, Shigella B13 strains are predicted to translate a stop codon rather than a tryptophan codon due to a single G-to-A transition
at the second codon position. Conserved residues thought to be important for enzymatic activity (11, 35) are highlighted in gray. Arrowheads
indicate residues that were mutated and shown to completely or partially abolish the cell cycle arrest activity of CDT (11, 35).

ers clpX_28F and clpX_411R were designed to amplify a region of clpX in all E. coli and Shigella strains as well as the
E. albertii lineage. A total of 134 E. coli and Shigella strains
representing all major pathotypes as well as all identified members of the E. albertii lineage were analyzed by PCR (data not
shown). The multiplex PCR was tested and validated with all
strains of the E. albertii lineage as well as representatives of
E. coli, Shigella, and Salmonella.
DISCUSSION
Following their discovery in 1991, isolates of eae-positive
H. alvei were described as distinct from eae-negative H. alvei
both phenotypically and genotypically (2, 3, 19–21, 43). These
unusual bacteria were unlike other diarrheagenic pathogens in
that they did not produce heat-labile and heat-stable enterotoxins or Shiga toxins and were not enteroinvasive. However, it
was shown that they were able to cause attaching-effacing lesions accompanied by diarrhea in rabbits, as well as the typical
pedestal formation and actin polymerization in vitro (2, 3, 19).
Twelve years after they were first discovered, the eae-positive
H. alvei isolates were elevated to a new species of pathogen
within the Enterobacteriaceae (18).

It has been recognized for nearly 50 years that Shigella B13
is highly divergent from other shigellae and has been classified
incorrectly (5, 14, 31, 40). For example, in a DNA relatedness
study, Shigella B13 was the only known group within the E. coliShigella complex that could be separated with certainty (5).
Later studies based on sequence analysis of multiple housekeeping genes confirmed that Shigella B13 is highly divergent
from E. coli and other Shigella serotypes (40). The key characteristic of typical Shigella strains is invasiveness due to the
presence of a large invasion plasmid, pINV (16). Although
Shigella B13 strains were originally considered to be Shigella,
there has been no evidence that they are invasive, nor do they
carry the known virulence genes present on pINV. Our analyses also failed to PCR amplify pINV genes in any of the
Shigella B13 strains or E. albertii strains examined by multilocus
virulence gene profiling.
We conclude, based on evolutionary analyses of multiple
housekeeping genes, the 16S rRNA gene, and putative virulence genes, that E. albertii and Shigella B13 strains are monophyletic and represent a distinct lineage of enteric pathogens
that separated from an ancient Escherichia ancestor after
E. coli and S. enterica had diverged from a common ancestor.
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FIG. 4. Cytopathic effects of bacterial cell extracts on HeLa cell monolayers. Cytoplasmic distension and nuclear abnormalities were apparent
72 h after HeLa cells were exposed to E. albertii and Shigella B7-related strains (A), whereas Shigella B13 strains did not appear to produce active
toxin (B). Included for comparison are CDT-negative E. coli K-12 (C) and CDT-positive E. coli 493/89 (D). Magnification, ⫻40.

On the basis of the rate of synonymous substitutions for E. coli
and S. enterica (4.7 ⫻ 10⫺9 per site per year) (42), the lineage
shared a common ancestor with E. coli ⬃28 million years ago.
The molecular evolutionary analysis supports the proposal that
certain strains, such as nontypeable strain 3097-02 and Shigella
B7-related strain K-1, should also be included in the new species,
E. albertii.
Although most Shigella B13 strains belong to the E. albertii
lineage, certain E. coli-Shigella-like strains (atypical Shigella
B13 strains) also express the Shigella B13 antigen, suggesting
there has been either horizontal transfer of genes responsible
for this phenotype or convergence to a similar antigenic phenotype. Atypical Shigella B13 strains 3556-77 and 3557-77 were
also detected as intermediate between E. coli and Shigella B13
strains by DNA relatedness, with levels similar to those found
between E. coli and Shigella B13 strain but lower than those
found within other Shigella B13 strains (5). The chemical and
genetic organization of the O antigen of Shigella B13 was recently described; based on nucleotide sequence data, the authors concluded that the Shigella B13 rfb gene cluster was
recently assembled and has also undergone recent evolutionary
change (15). The inclusion of nontypeable and Shigella B7-

related strains in the E. albertii lineage and the evidence for
change in the genes responsible for antigenic variations suggest
that the lineage may be very diverse, but that diversity has probably been seriously underestimated because of sampling bias.
To explore putative virulence factors present in the E. albertii lineage, we described two genes that E. albertii strains are
known to express, the intimin (eae) (3) and CDT (cdt) (38)
genes, and screened the strains for the presence of other known
E. coli and Shigella virulence factors. Phylogenetic analyses of
virulence genes revealed three subclusters within the E. albertii
lineage, consistent with phylogenetic analyses of multiple housekeeping genes, and supported the conclusion that these strains
belong to an evolutionary branch of enteric pathogens that
have further diverged into three distinct groups.
The intimin gene (eae), which was found to be present in all
members of the E. albertii lineage by virulence gene profiling,
was sequenced in representatives of the E. albertii subclusters.
Phylogenetic analyses indicated that the sequences of Shigella
B13 strains, which are identical, are similar to the sequence of
the iota2 allele of pathogenic E. coli. The sequences of strains
19982 (E. albertii) and K-1 (Shigella B7 related) are similar to
the sequence of the iota2 allele in the central conserved region
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TABLE 4. Presence or absence of E. coli and Shigella virulence genes in the E. albertii-Shigella B13 lineage as
detected by multilocus virulence gene profilinga
Presence (⫹) or absence (⫺) of the indicated gene in:
E. coli
Strain

Shigella (chromosomal)

Lineage
O43

9194
10457
10790
12502
19982
2045-51
2046-51
1610-55
603-73
3552-77
3553-77
3554-77
3555-77
3103-99
3097-02
C-425
616
K-694
K-1
5216-70
3556-77
3557-77
3052-94
3053-94

E. albertii
E. albertii
E. albertii
E. albertii
E. albertii
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B13
Shigella B7
Atypical Shigella
Atypical Shigella
Atypical Shigella
Atypical Shigella
Atypical Shigella

B13
B13
B13
B13
B13

ureA

terC

iha

LEE
(eae)

⫹
⫺
⫹
⫺
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫺
⫹
⫺
⫹
⫹
⫺
⫺
⫺
⫺

⫹
⫺
⫹
⫺
⫺
⫹
⫺
⫹
⫺
⫺
⫹
⫺
⫹
⫹
⫹
⫺
⫹
⫺
⫺
⫺
⫺
⫺
⫺
⫺

⫺
⫺
⫺
⫺
⫺
⫹
⫺
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫺
⫹
⫺
⫹
⫺
⫹

⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫺
⫹
⫹
⫹
⫹

Plasmid

c/p
(astA)

pO157
(toxB)

ehx

pet

sigA

pic

shuA

set1a

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫹
⫹
⫺
⫹

⫺
⫹
⫹
⫹
⫹
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫺
⫺
⫹

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫹

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫺

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫺
⫹
⫺
⫺

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫺
⫺
⫺
⫺
⫺
⫺

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫹
⫹
⫺

⫺
⫺
⫹
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫹
⫹
⫺
⫹
⫺
⫺
⫺
⫺
⫺
⫺

a
Abbreviations: O43, O island 43 E. coli O157:H7 EDL-933; LEE, locus of enterocyte effacement; c/p, duplicate copies exist, one chromosomal and one carried on
a plasmid. All strains were found to be negative by PCR for espP, espC, sepA, sat, stx1, stx2, saa, spaP, invG, shuA, cdtA, irp2, fyuA, senA, estA, bfpA, and elt.

but have different alleles most similar to the alpha and zeta
alleles of E. coli in the Int280 region.
CDT activity does not appear to be required for the virulence of E. albertii and its relatives. In two Shigella B13 strains
(3553-77 and 3555-77), originally isolated from human patients, the cdtB gene was not amplified by PCR with degenerate primers; the remainder of the Shigella B13 strains contained a putative stop codon and lacked CDT activity. The
silencing of CDT expression suggests that it does not have a
required role in the virulence of these organisms. The short
evolutionary distance between the active E. albertii cdt alleles
and the inactive Shigella B13 cdt alleles suggests that the inactivation was a recent evolutionary event.
Both virulence genes examined have a lower GC content
and a lower codon adaptation index, as measured by the rate of
amelioration of GC content at the third codon positions, than
do housekeeping genes (Table 3). The low codon adaptation
index suggests recent acquisition of the virulence genes by
lateral gene transfer. In particular, cdt sequences have a very
low codon adaptation index. Levels of polymorphism within
the E. albertii lineage are similar between the virulence and
housekeeping genes, with the exception of the 3⬘ Int280 region
of eae. The sequence diversity of this extracellular region in
E. coli strains is thought to be under positive selection (33),
and the sequence diversity in the E. albertii lineage supports
the hypothesis that in the E. albertii lineage, as in E. coli,
positive selection drives sequence divergence in this region.
To facilitate the economical screening of isolates, a diagnostic multiplex PCR was designed to identify bacteria of the

E. albertii lineage based on sequence variations in housekeeping genes. This method of classification is independent of biochemical and antigenic phenotypes and therefore may provide
a useful starting point for discovering genetic and antigenic
diversity within the lineage. Infection by members of the E. albertii lineage may contribute to unexplained diarrhea, and molecular markers for the rapid detection of the new lineage will
be crucial to further elucidating the role of these novel organisms in enteric disease.
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